Gpt Healthcare Share Price
Sector: Healthcare Facilities
154.60 +0.75 (0.49%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
153.45
Today’s High
156.30
52 Week Low
126.15
52 Week High
206.50
154.72 -0.15 (-0.10%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
153.29
Today’s High
157.44
52 Week Low
126.10
52 Week High
208.45
Key Metrics
- Market Cap (In Cr) 1251.88
- Beta -
- Div. Yield (%) 1.62
- P/B 5.8
- TTM P/E 30.13
- Sector P/E 23.39
- Open Price 155.6
- Prev Close 153.85
Gpt Healthcare Analysis
Price Analysis
-
1 Week-5.63%
-
3 Months-7.09%
-
6 Month-11.03%
-
YTD-16%
-
1 Year-9.24%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Gpt Healthcare News
DxGPT: How Microsoft’s AI is helping families find diagnoses for rare diseases
2 min read . 28 Apr 2025Hospital stocks rise as govt plans daycare cancer centers in district hospitals
2 min read . 01 Feb 2025Multibagger IPOs: 12 companies soar over 100% from issue price in Samvat 2080
4 min read . 29 Oct 2024Stocks to Watch: UltraTech Cement, AU Small Finance Bank, Vedanta, and more
3 min read . 27 Aug 2024Gpt Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 400.19
- Selling/ General/ Admin Expenses Total
- 97.87
- Depreciation/ Amortization
- 17.98
- Other Operating Expenses Total
- 130.41
- Total Operating Expense
- 328.84
- Operating Income
- 71.35
- Net Income Before Taxes
- 68.04
- Net Income
- 47.77
- Diluted Normalized EPS
- 5.95
- Period
- 2024
- Total Assets
- 345.52
- Total Liabilities
- 127.03
- Total Equity
- 218.49
- Tangible Book Valueper Share Common Eq
- 26.52
- Period
- 2024
- Cashfrom Operating Activities
- 68.8
- Cashfrom Investing Activities
- -25.21
- Cashfrom Financing Activities
- -48.5
- Net Changein Cash
- -4.91
- Period
- 2023
- Total Revenue
- 361.04
- Selling/ General/ Admin Expenses Total
- 66.19
- Depreciation/ Amortization
- 14.91
- Other Operating Expenses Total
- 143.58
- Total Operating Expense
- 301.23
- Operating Income
- 59.8
- Net Income Before Taxes
- 55.97
- Net Income
- 39.01
- Diluted Normalized EPS
- 4.77
- Period
- 2023
- Total Assets
- 326.76
- Total Liabilities
- 161.39
- Total Equity
- 165.36
- Tangible Book Valueper Share Common Eq
- 20.1
- Period
- 2023
- Cashfrom Operating Activities
- 66.35
- Cashfrom Investing Activities
- 5.15
- Cashfrom Financing Activities
- -73.18
- Net Changein Cash
- -1.67
- Period
- 2022
- Total Revenue
- 337.42
- Selling/ General/ Admin Expenses Total
- 56.7
- Depreciation/ Amortization
- 13.59
- Other Operating Expenses Total
- 118.97
- Total Operating Expense
- 276.65
- Operating Income
- 60.77
- Net Income Before Taxes
- 54.08
- Net Income
- 41.66
- Diluted Normalized EPS
- 5.09
- Period
- 2022
- Total Assets
- 323.22
- Total Liabilities
- 165.04
- Total Equity
- 158.18
- Tangible Book Valueper Share Common Eq
- 19.27
- Period
- 2022
- Cashfrom Operating Activities
- 65.99
- Cashfrom Investing Activities
- -5.34
- Cashfrom Financing Activities
- -57.16
- Net Changein Cash
- 3.49
- Period
- 2021
- Total Revenue
- 242.75
- Selling/ General/ Admin Expenses Total
- 43.27
- Depreciation/ Amortization
- 12.47
- Other Operating Expenses Total
- 92.98
- Total Operating Expense
- 205.99
- Operating Income
- 36.76
- Net Income Before Taxes
- 28.88
- Net Income
- 21.09
- Diluted Normalized EPS
- 2.51
- Period
- 2021
- Total Assets
- 317.21
- Total Liabilities
- 183.31
- Total Equity
- 133.9
- Tangible Book Valueper Share Common Eq
- 16.31
- Period
- 2021
- Cashfrom Operating Activities
- 43.93
- Cashfrom Investing Activities
- -17.38
- Cashfrom Financing Activities
- -22.11
- Net Changein Cash
- 4.43
- Period
- 2020
- Total Revenue
- 211.84
- Selling/ General/ Admin Expenses Total
- 45.99
- Depreciation/ Amortization
- 11.08
- Other Operating Expenses Total
- 91.42
- Total Operating Expense
- 186.9
- Operating Income
- 24.95
- Net Income Before Taxes
- 14.84
- Net Income
- 10.96
- Diluted Normalized EPS
- 1.34
- Period
- 2020
- Total Assets
- 308.46
- Total Liabilities
- 181.64
- Total Equity
- 126.82
- Tangible Book Valueper Share Common Eq
- 15.44
- Period
- 2020
- Cashfrom Operating Activities
- 41.46
- Cashfrom Investing Activities
- -54.31
- Cashfrom Financing Activities
- 11.91
- Net Changein Cash
- -0.93
- Period
- 2019
- Total Revenue
- 171.87
- Selling/ General/ Admin Expenses Total
- 34.2
- Depreciation/ Amortization
- 9
- Other Operating Expenses Total
- 69.78
- Total Operating Expense
- 143.66
- Operating Income
- 28.21
- Net Income Before Taxes
- 20.38
- Net Income
- 14.95
- Diluted Normalized EPS
- 1.82
- Period
- 2019
- Total Assets
- 257.66
- Total Liabilities
- 141.84
- Total Equity
- 115.82
- Tangible Book Valueper Share Common Eq
- 14.08
- Period
- 2019
- Cashfrom Operating Activities
- 32.39
- Cashfrom Investing Activities
- -30.98
- Cashfrom Financing Activities
- -0.38
- Net Changein Cash
- 1.03
- Period
- 2024-12-31
- Total Revenue
- 102.21
- Selling/ General/ Admin Expenses Total
- 18.51
- Depreciation/ Amortization
- 4.67
- Other Operating Expenses Total
- 42.26
- Total Operating Expense
- 85.61
- Operating Income
- 16.59
- Net Income Before Taxes
- 17.62
- Net Income
- 12.25
- Diluted Normalized EPS
- 1.49
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 105.66
- Selling/ General/ Admin Expenses Total
- 17.73
- Depreciation/ Amortization
- 4.8
- Other Operating Expenses Total
- 44.18
- Total Operating Expense
- 87.04
- Operating Income
- 18.62
- Net Income Before Taxes
- 20.69
- Net Income
- 14.82
- Diluted Normalized EPS
- 1.81
- Period
- 2024-09-30
- Total Assets
- 346.75
- Total Liabilities
- 115.77
- Total Equity
- 230.97
- Tangible Book Valueper Share Common Eq
- 28
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 24.7
- Cashfrom Investing Activities
- -4.45
- Cashfrom Financing Activities
- -18.7
- Net Changein Cash
- 1.55
- Period
- 2024-06-30
- Total Revenue
- 97.82
- Selling/ General/ Admin Expenses Total
- 18.72
- Depreciation/ Amortization
- 4.68
- Other Operating Expenses Total
- 42.78
- Total Operating Expense
- 84.53
- Operating Income
- 13.29
- Net Income Before Taxes
- 14.67
- Net Income
- 9.96
- Diluted Normalized EPS
- 1.21
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 99.43
- Selling/ General/ Admin Expenses Total
- 17
- Depreciation/ Amortization
- 4.76
- Other Operating Expenses Total
- 38.47
- Total Operating Expense
- 81.01
- Operating Income
- 18.42
- Net Income Before Taxes
- 18.41
- Net Income
- 12.82
- Diluted Normalized EPS
- 1.59
- Period
- 2024-03-31
- Total Assets
- 345.52
- Total Liabilities
- 127.03
- Total Equity
- 218.49
- Tangible Book Valueper Share Common Eq
- 26.52
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 68.8
- Cashfrom Investing Activities
- -25.21
- Cashfrom Financing Activities
- -48.5
- Net Changein Cash
- -4.91
- Period
- 2023-12-31
- Total Revenue
- 96.59
- Selling/ General/ Admin Expenses Total
- 17.26
- Depreciation/ Amortization
- 4.5
- Other Operating Expenses Total
- 38.63
- Total Operating Expense
- 80.09
- Operating Income
- 16.5
- Net Income Before Taxes
- 15.99
- Net Income
- 11.47
- Diluted Normalized EPS
- 1.44
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 107.98
- Selling/ General/ Admin Expenses Total
- 17.44
- Depreciation/ Amortization
- 4.39
- Other Operating Expenses Total
- 43.55
- Total Operating Expense
- 87.76
- Operating Income
- 20.21
- Net Income Before Taxes
- 19.49
- Net Income
- 13.5
- Diluted Normalized EPS
- 1.69
- Period
- 2023-09-30
- Total Assets
- 332.09
- Total Liabilities
- 159.44
- Total Equity
- 172.65
- Tangible Book Valueper Share Common Eq
- 20.94
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 34
- Cashfrom Investing Activities
- -6.34
- Cashfrom Financing Activities
- -29.98
- Net Changein Cash
- -2.33
- Period
- 2023-03-31
- Total Revenue
- 361.04
- Selling/ General/ Admin Expenses Total
- 66.19
- Depreciation/ Amortization
- 14.91
- Other Operating Expenses Total
- 143.58
- Total Operating Expense
- 301.23
- Operating Income
- 59.8
- Net Income Before Taxes
- 55.97
- Net Income
- 39.01
- Diluted Normalized EPS
- 4.77
- Period
- 2023-03-31
- Total Assets
- 326.76
- Total Liabilities
- 161.39
- Total Equity
- 165.36
- Tangible Book Valueper Share Common Eq
- 20.1
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 66.35
- Cashfrom Investing Activities
- 5.15
- Cashfrom Financing Activities
- -73.18
- Net Changein Cash
- -1.67
- Period
- 2022-09-30
- Total Revenue
- 171.97
- Selling/ General/ Admin Expenses Total
- 33.56
- Depreciation/ Amortization
- 6.93
- Other Operating Expenses Total
- 71.39
- Total Operating Expense
- 148.3
- Operating Income
- 23.67
- Net Income Before Taxes
- 21.64
- Net Income
- 16.99
- Diluted Normalized EPS
- 2.07
- Period
- 2022-09-30
- Total Assets
- 324.45
- Total Liabilities
- 165.26
- Total Equity
- 159.19
- Tangible Book Valueper Share Common Eq
- 19.38
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 22.76
- Cashfrom Investing Activities
- 10.15
- Cashfrom Financing Activities
- -38.59
- Net Changein Cash
- -5.67
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Gpt Healthcare Technical
Moving Average
SMA
- 5 Day158.67
- 10 Day162.36
- 20 Day162.65
- 50 Day148.29
- 100 Day162.55
- 300 Day169.87
Gpt Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Shalby
- 186.85
- -2.7
- -1.42
- 325
- 180
- 2018.17
- Dr. Agarwal's Eye Hospital
- 4185
- 38.25
- 0.92
- 7300
- 2800
- 1984.05
- Gpt Healthcare
- 154.6
- 0.75
- 0.49
- 206.5
- 126.15
- 1251.88
- Forbes And Company
- 364.1
- 7.1
- 1.99
- 796.2
- 264.35
- 469.64
- Kerala Ayurveda
- 342.85
- -4.35
- -1.25
- 486.9
- 250
- 406.91
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Shalby
- 24.27
- 2.04
- 6.37
- 8.2
- Dr. Agarwal's Eye Hospital
- 41.89
- 12.4
- 29.64
- 10.83
- Gpt Healthcare
- 26.04
- 5.82
- 21.36
- 10.33
- Forbes And Company
- 81.16
- 3.28
- -173.02
- -11.35
- Kerala Ayurveda
- -
- 12.99
- -2.12
- 0.07
Gpt Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results & Interim Dividend
- 13-Aug-24
- Quarterly Results
- 21-May-24
- Audited Results & Final Dividend
- 19-Mar-24
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 25-Jul-24
- 21-May-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-Nov-24
- 28-Nov-24
- 28-Nov-24
- 1
- 21-May-24
- -
- 18-Jul-24
- 1.5
- 19-Mar-24
- 02-Apr-24
- 02-Apr-24
- 1


